Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
about
In vitro human cell line models to predict clinical response to anticancer drugsPharmacogenomics of chemotherapeutic susceptibility and toxicityPharmacogenomic discovery using cell-based modelsHeritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.The use of genomic information to optimize cancer chemotherapyGermline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancersLymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model.Chemotherapeutic-induced apoptosis: a phenotype for pharmacogenomics studies.Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy.Identification of novel germline polymorphisms governing capecitabine sensitivity.Pharmacogenomics of platinum-based chemotherapy in NSCLCRelating human genetic variation to variation in drug responses.Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy.A combined-cross analysis reveals genes with drug-specific and background-dependent effects on drug sensitivity in Saccharomyces cerevisiae.PlGF knockdown inhibited tumor survival and migration in gastric cancer cell via PI3K/Akt and p38MAPK pathways.Human lymphoblastoid cell lines: a goldmine for the biobankomics era.Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants.Overview of linkage analysis in complex traits.PlGF Knockdown Decreases Tumorigenicity and Stemness Properties of Spheroid Body Cells Derived from Gastric Cancer Cells.Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients
P2860
Q27000665-CC1D3984-CE6F-498E-9408-D65D60B46A22Q27025558-0189BFC9-F6FF-43F8-AA8C-163115B3446AQ28392982-04D76A5E-C567-44D5-AA44-53E28CD62E41Q34288272-D83AFA79-28EC-44D0-87DB-84B0EA4FC7F6Q34791981-411BF746-5566-464C-AC50-F90FB5875C47Q34820601-E20E2E22-8508-4AF2-8A2C-9EE89984F9BAQ35068272-E15485E4-1539-48B9-A339-2768B1F6B28AQ35099987-B723A179-AC46-4DD4-908A-D4A12E8109CDQ35114557-23486E04-F164-4F56-8E4D-6089A31EA60EQ35196480-222AE161-B63F-4BBD-B64B-D0CACC50A4A4Q36147462-333A6297-DE28-42D1-9622-C8128A4D4F11Q36158678-8B05ECDA-CF66-43B1-B1BC-48D1587D5D7AQ36252524-6391FC52-2246-4863-8C7C-9C91BA059D78Q36545157-68BEC5B5-F89A-47C4-B40E-8E772BBEB489Q37424977-981ED86E-8535-4E98-B315-B155968F3234Q38787028-965D93DD-5D7B-40D2-8BFC-25AB475FA3C6Q39520813-D756CB63-517C-4740-9BBA-18DC82BE8AA1Q39714590-CDD39934-501E-4D11-B7D7-9724244D27F5Q44367952-3495364A-6A3C-46E5-A58C-B02F888FBAA2Q51398885-1BC1B4B7-6380-4CD8-93A7-06BFA68C3BBFQ55561308-3AA65B6A-4CC9-4EE2-AD5A-E0F2F53F3193
P2860
Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
@en
Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
@nl
type
label
Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
@en
Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
@nl
prefLabel
Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
@en
Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
@nl
P2093
P2860
P1433
P1476
Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
@en
P2093
Judith A Badner
Kristen Kasza
M Eileen Dolan
Shiwei Duan
Sunita J Shukla
Xiaolin Wu
P2860
P2888
P304
P356
10.1186/1479-7364-3-2-128
P577
2009-01-01T00:00:00Z
P5875
P6179
1039432265